PIPELINE

0
INDICATIONS

OUR FOCUS

We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our uniqe, behaviour based zebrafish screening technology.

Indication Product Drug discovery Preclinical Phase I Phase II Phase III
ADHD C-51
Parkinson's TBA
Schizoprenia TBA
EDS TBA